|
| Tuesday, 6 December 2011, 16:30 HKT/SGT | |
| |  | |
Source: A*STAR | |
|
|
|
SINGAPORE, Dec 6, 2011 - (ACN Newswire) - The A*STAR Institute of Microelectronics (IME) and Tezzaron Semiconductor, a leader in 3D-ICs, have today announced a research collaboration agreement to develop and exploit advanced Through Silicon Interposer (TSI) technology. The two organizations will improve and refine the design and manufacture of silicon interposers and work to standardize the process, flows, and process design kits (PDKs). Initial early production devices are already in development, based on IME's TSI technology and incorporating 3D-ICs from Tezzaron. Fabrication will be completed in IME's state-of-the-art 300mm R&D Fab.
The resulting TSI technology from the collaboration will form the foundation for the TSI Consortium driven by IME, to be launched in early 2012. The TSI Consortium aims to optimise TSI technology through functional demonstration of 2.5D systems for cost effective and performance-driven applications.
IME and Tezzaron have a history of cooperation dating back to 2001 when IME provided its copper line technologies to Tezzaron for their wafer stacking endeavors. IME has performed important research on many aspects of 3D IC technology including Through-Silicon Vias (TSVs), cooling, interconnects and interposers, while Tezzaron has focused on designing and building wafer-stacked 3D-ICs in its FaStack(R) process. The new research collaboration builds on the strengths of both organizations.
"This is a strategic partnership aimed at accelerating the full adoption of 2.5D/3D-IC," commented Professor Dim-Lee Kwong, Executive Director of IME. "To build momentum in customer adoption and technology, IME will launch a TSI Consortium in early 2012, to facilitate greater cooperation between foundry, outsourced semiconductor assembly and test providers (OSATs), equipment vendors and supply chain partners to expedite the integration of the supply chain. In the near future, we plan to develop TSI technology for MEMS and silicon photonics to extend the benefits of 3D-IC technology to a wider range of applications."
"Silicon interposer technology is more than a bridge technology; it is a vital component for heterogeneous system integration. Advanced silicon interposers will be an extremely valuable addition to our 3D-IC offerings," says Robert Patti, CTO of Tezzaron. "This critical collaboration with a leading research institute will allow the technology to reach a broader market quickly and cost effectively."
About 2.5D/3D Integration
In true 3D-IC technology, designers arrange their circuitry across several layers of silicon that are manufactured separately and then stacked and tightly integrated into a single chip. The benefits are enormous, but the design effort is considerable. Interposers, on the other hand, allow designers to integrate existing chips side-by-side on an interconnecting surface, analogous to a circuit card but offering a significant performance advantage. This is generally called "2.5D" technology as it offers some of the key advantages of 3D technology. Even compared to full 3D, active silicon interposers offer attractive advantages: they can accommodate very large circuits that would overwhelm today's 3D capabilities, their larger surface area dissipates heat more readily, and existing chips can be rapidly assimilated into the design.
About Tezzaron(R)
Tezzaron(R) Semiconductor (USA and Singapore) specializes in 3D wafer stacking and TSV processes, cutting edge memory products, and wide-ranging collaborations. In 2004 Tezzaron demonstrated the world's first successful wafer-stacked 3D-ICs with TSV including microprocessors, sensors, and SRAM devices. Since that time the company has worked with dozens of customers to create custom 3D-ICs for prototyping and commercialization. The company has produced extremely fast memory prototypes and builds memory devices for both standalone and stacked applications. Information about Tezzaron is available at http://www.tezzaroncom/.
About Institute of Microelectronics (IME)
The Institute of Microelectronics (IME) is a research institute of the Science and Engineering Research Council of the Agency for Science, Technology and Research (A*STAR). Positioned to bridge the R&D between academia and industry, IME's mission is to add value to Singapore's semiconductor industry by developing strategic competencies, innovative technologies and intellectual property; enabling enterprises to be technologically competitive; and cultivating a technology talent pool to inject new knowledge to the industry. Its key research areas are in integrated circuits design, advanced packaging, bioelectronics and medical devices, MEMS, nanoelectronics, and photonics. For more information, visit IME on the Internet: http://www.ime.a-star.edu.sg.
Contact:
Gretchen Patti
Tezzaron Semiconductor
DID: +1 630 505 0404
Email: gpatti@tezzaron.com
Cindy Chew
Institute of Microelectronics
DID: +65 6770 5375
Email: chewwfc@ime.a-star.edu.sg
Topic: New Product
Source: A*STAR
Sectors: Electronics, Optoelectronics
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| A*STAR |
| Dec 6, 2022 14:00 HKT/SGT |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| June 2, 2022 21:00 HKT/SGT |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Sept 30, 2021 16:00 HKT/SGT |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| July 31, 2020 08:00 HKT/SGT |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| July 24, 2020 17:00 HKT/SGT |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| Oct 22, 2019 04:00 HKT/SGT |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| June 28, 2019 08:00 HKT/SGT |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| Apr 5, 2019 18:00 HKT/SGT |
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| Jan 21, 2019 13:00 HKT/SGT |
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| More news >> |
 |
|
|
|
